Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-126Z for seasonal allergic rhinitis (Phase III, China)
CTR20201737Phase 3Completed
- Sponsor
- Nippon Shinyaku
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine + fluticasone in seasonal allergic rhinitis (SAR), sponsored by Nippon Shinyaku. Started Sep 2020; status: completed.
02
Drugs
azelastine + fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20201737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201737.